Literature DB >> 26088327

Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.

Pouria Heydarpour1, Shayan Khoshkish, Shabnam Abtahi, Maziar Moradi-Lakeh, Mohammad Ali Sahraian.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is one of the most common neurological disorders and a leading cause of nontraumatic disability in young adults in many countries. Recent reports from the Middle East and North Africa have suggested a moderate to high risk of MS in these countries.
METHODS: A literature search was performed in August 2014 in MEDLINE, EMBASE, and IMEMR to retrieve original population-based studies on MS epidemiology in the Middle East and North African countries published between 1st January 1985 and 1st August 2014. We designed search strategies using the key words: MS, prevalence, incidence, and epidemiology. According to the inclusion criteria, 52 studies were included in this systematic review.
RESULTS: McDonald's criteria were the most widely used diagnostic criteria in the studies. Most studies were conducted in single hospital-based centers with a defined catchment area. The female/male ratio ranged from 0.8 in Oman to 4.3 in Saudi Arabia. MS prevalence ranged from 14.77/100,000 population in Kuwait (2000) to 101.4/100,000 in Turkey (2006). The overall MS prevalence in the region was 51.52/100,000. The mean age at disease onset ranged from 25.2 years in Kuwait to 32.5 years in Northeastern Iran, with an overall estimate of 28.54 years.
CONCLUSIONS: Recent advances in MS registries will allow nation-wide studies and temporal comparisons between countries, provided that age- and sex-standardized estimates are available.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26088327     DOI: 10.1159/000431042

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  42 in total

Review 1.  Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.

Authors:  Samira Paul; Aeysha Brown; Abbey J Hughes
Journal:  Neuropsychol Rev       Date:  2019-05-17       Impact factor: 7.444

2.  Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

Authors:  Sara Salama; Hazem Marouf; M Ihab Reda; Amal R Mansour; Osama ELKholy; Michael Levy
Journal:  J Neuroimmunol       Date:  2018-08-29       Impact factor: 3.478

3.  Cultural Adaptation, Validity, and Factor Structure of the Jalowiec Coping Scale in Iranian Women with Multiple Sclerosis: Which Coping Strategies Are Most Common and Effective?

Authors:  Mohsen Saffari; Hormoz Sanaeinasab; Mahrokh Hashempour; Amir H Pakpour; Jesus F Lovera; Saad Al Shohaib
Journal:  Int J MS Care       Date:  2017 Jul-Aug

4.  A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Reza Shiri-Shahsavar; Abbas Mirshafiee; Karim Parastouei; Abbas Ebrahimi-Kalan; Saeed Yekaninejad; Farid Soleymani; Reza Chahardoli; Ramin Mazaheri Nezhad Fard; Ali Akbar Saboor-Yaraghi
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

5.  Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale.

Authors:  Cansu Polat; Zeliha Tülek; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

6.  Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia.

Authors:  Esraa Q Alsaedi; Marwa Q Alsaedi; Farah A Mansuri
Journal:  Cureus       Date:  2022-06-11

7.  Stroke and seizure continue to be the major brunt of in patient neurology care. An observation from teaching hospital.

Authors:  Azra Zafar; Majed Alabdali; Rizwana Shahid; Danah Aljaafari; Fahd A Al-Khamis; Aishah I Albakr; Saima Nazish; Abdulla A Al-Sulaiman; Alon Abraham
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

8.  Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.

Authors:  Zeliha Tülek; Cansu Polat; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2016-04-26       Impact factor: 1.339

Review 9.  Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review.

Authors:  Mohammad Hosein Farzaei; Zahra Shahpiri; Roodabeh Bahramsoltani; Marjan Moghaddam Nia; Fariba Najafi; Roja Rahimi
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 6.497

10.  Translation and Validation of the Turkish Version of Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Authors:  Öznur Usta Yeşilbalkan; Öznur Erbay; Ayşe Nur Yüceyar
Journal:  Noro Psikiyatr Ars       Date:  2018-11-28       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.